Quantifying Barriers to Diabetic Eye Screening: A Two-Center Study at the University of California.
retrospective_cohort · Level III
Where this comes from
- Record sourced from PubMed, PMID 40924935.
- Also identified by DOI 10.2337/dc25-0951 and PMC identifier 12583403.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study aimed to evaluate the diabetic eye disease screening continuum at two academic centers and identify its barriers. We analyzed health records from the University of California, San Francisco, and University of California, Irvine, to identify primary care patients needing diabetic eye screening. We tracked referrals, screenings, diagnoses, and treatments to evaluate predictors and the impact of an automated referral system. We analyzed physician notes using GPT-4o to determine reasons for missed screenings. Of 8,240 unscreened patients with type 2 diabetes mellitus (T2DM), 43% received a referral, and only 16% completed screening within 1 year. Demographic, provider, and socioeconomic factors predicted adherence, with referrals being the strongest predictor. An automated referral system could improve screening rates to 22-34%. Clinician notes cited comorbidities, scheduling challenges, logistical issues, coronavirus disease 2019, and personal circumstances as barriers. Many patients with T2DM remain unscreened after primary care visits. Although an automated referral system may partially improve adherence, additional tailored strategies are needed.
Medical subject headings
- Diabetes Mellitus, Type 2
- Diabetic Retinopathy
- Mass Screening